Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention
Cross-protection from human papillomavirus 16/18 against types 45 and 31
The need for actions to effectively prevent cervical cancer
HPV and cervical cancer
Cervical cancer screening could be cost-effective, if current US guidelines are updated
A woman's sexual debut carries a high HPV risk
New HPV-detection assay increases the number of women followed-up
New therapeutic vaccine shows potential
Extended follow up suggests antibody levels remain high 6 years after vaccination with Cervarix®
HPV DNA testing may be more effective in detecting precancerous cervical lesions than Pap smears
Sexual risk assessment is not helpful for recommendations on human papillomavirus vaccination
Expecting the unexpected
High risk of human papillomavirus infection with a young woman's first sexual partner reinforces the importance of vaccinating early
Surveillance of human papillomavirus infections and disease in the vaccine era
Sound implementation of human papillomavirus vaccination as a community-randomized trial
Human papillomavirus screening and vaccines for cancer prevention
Evaluating the potential benefits of universal worldwide human papillomavirus vaccination
Prophylactic human papillomavirus vaccines to prevent cervical cancer
Efficacy of a prophylactic human papillomavirus vaccine against high-grade vulval and vaginal intraepithelial neoplasia
Prevention of cervical cancer in developing countries
Therapeutic human papillomavirus vaccination
Reduction of stroke and all-cause mortality in the very elderly using antihypertensive treatment
Psoriatic arthritis symptoms may be relieved with long-term infliximab therapy
Oral mini-pulse therapy shows potential in treatment of oral lichen planus
Individualized patient management for breast cancer
Treatment of bipolar I disorder with tamoxifen offers hope in the treatment of mania symptoms
Tadalafil in the treatment of lower urinary tract symptoms and erectile dysfunction
What is the clinical utility of interferon-γ release assays for the diagnosis of TB in high-TB-burden countries?